Beijing Tide Pharmaceutical Co., Ltd

This study tests a new drug called TCC1727 combined with other cancer treatments (benmelstobart, olaparib, or topotecan) in people with advanced solid tumors like lung, stomach, endometrial, or melanoma. The goal is to find the safest and most effective dose and see if the combin…

This study tests a new drug called TDI01 for people with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and makes breathing hard. About 508 adults in China will take either TDI01 or a placebo for up to a year. The goal is to see if TDI01 can slow lung fu…

This study tests a new painkiller called TRD205 for people recovering from hip replacement surgery. About 200 adults will receive either TRD205, an active comparator, or a placebo to see how well it controls pain and reduces the need for extra pain medication. The goal is to find…

This early-stage study tests the safety and how the body handles an inhaled drug called CPD704. It involves 90 healthy Chinese adults aged 18-55. The goal is to check for side effects and measure drug levels in the blood, not to treat any disease.